{"mainPropery":{"diseaseId":4380,"diseaseName":"Type 1 plasminogen deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4380/type-1-plasminogen-deficiency","synonyms":["Hypoplasminogenemia"],"synonyms-with-source":[{"name":"Hypoplasminogenemia"}],"identifiers":[{"identifierType":"OMIM","identifierId":"217090"},{"identifierType":"ORPHANET","identifierId":"722"},{"identifierType":"UMLS","identifierId":"C0398621"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3551,"resourceName":"American Thrombosis & Hemostasis Network","abbreviation":"ATHN","address1":"","address2":"","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"","country":"United States","phone":"","tty":"","tollFree":"800-360-2846","fax":"847-572-0967","email":"info@athn.org","url":"https://athn.org/","freeText":"Contact form: https://athn.org/?q=contact"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/217090' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%28%28%22plasminogen%22%5BMeSH+Terms%5D+OR+%22plasminogen%22%5BAll+Fields%5D%29+AND+%28%22deficiency%22%5BSubheading%5D+OR+%22deficiency%22%5BAll+Fields%5D%29+AND+type%5BAll+Fields%5D+AND+1%5BAll+Fields%5D%29+AND+%28%22loattrfull+text%22%5Bsb%5D+AND+%22loattrfree+full+text%22%5Bsb%5D+AND+hasabstract%5Btext%5D+AND+%222003%2F12%2F11%22%5BPDat%5D+%3A+%222008%2F12%2F08%22%5BPDat%5D+AND+English%5Blang%5D%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Type 1 plasminogen deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://www.clinicaltrials.gov/ct2/results?term=plasminogen+deficiency&Search=Search' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Type 1 plasminogen deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Type 1 plasminogen deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/congenital-plasminogen-deficiency/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=8694&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:217090' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1368,"questionText":"What is type 1 plasminogen deficiency?","answerText":"<strong>Type 1 plasminogen deficiency</strong> is a genetic condition&nbsp;associated with inflammed growths on the mucous membranes, the moist tissues that line body openings such as the eye, mouth, nasopharynx, trachea, and female genital tract.  The growths may be triggered by local injury and/or infection and often recur after removal. The growths are caused by the deposition of&nbsp;fibrin (a protein involved in blood clotting) and by&nbsp;inflammation. The most common clinical finding is ligneous ('wood-like') conjunctivitis, a condition marked by redness and subsequent formation of pseudomembranes of part of the eye that progresses to white, yellow-white or red thick masses with a wood-like consistency that replace the normal mucosa. This can lead to vision loss. Growths in other areas can also lead to medical problems; those that occur in the gastrointestinal tract can cause ulcers, and growth in the windpipe can lead to breathing problems. <a href=\"https://www.nlm.nih.gov/medlineplus/hydrocephalus.html\" target=\"_blank\">Hydrocephalus</a>&nbsp;may be&nbsp;present at birth in&nbsp;a small number of individuals.[824][11690] Type 1 plasminogen deficiency is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/PLG\" target=\"_blank\">PLG</a></em> gene. It is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;pattern.[11690] Management depends upon the sites involved, but mainly focuses on managing the ligneous conjunctivitis.[11691]","dateModified":"2016-06-13T00:00:00"},"basicQuestions":[{"questionId":1394,"questionText":"What are the signs and symptoms of type 1 plasminogen deficiency?","answerText":"Type 1 plasminogen deficiency is characterized by the formation of inflamed growths on the mucous membranes. The area of the body most commonly affected is the conjunctiva, which are the mucous membranes that protect the white part of the eye (the sclera) and line the eyelids. The most common symptom&nbsp;of this disorder is ligneous conjunctivitis. This occurs when a buildup of a protein called fibrin causes inflammation of the conjunctiva (conjunctivitis), leading to thick, woody (ligneous), inflamed growths. The growths usually appear yellow, white, or red in color. Ligneous conjunctivitis most often occurs on the inside of the eyelids. These growths can lead to tearing of the cornea, scarring, and vision loss.&nbsp;<br />\r\n<br />\r\nOther, less commonly affected areas include the inside of the mouth and gums, ears, upper and lower gastrointestinal tract, lungs, and female reproductive tract. The central nervous system (brain and spinal cord) and skin may also be affected.[823][5987][11691]","dateModified":"2016-06-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":823,"authors":"Tefs K, Gueorguieva M, Klammt J, Allen CM, Aktas D, Anlar FY et al","articleTitle":"Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients","bookWebsiteJournalTitle":"Blood","date":"November 2006","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/16849641","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5987,"authors":"","articleTitle":"Congenital plasminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","url":"http://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","dateAccessed":"2013-04-29T00:00:00"},{"referenceId":11691,"authors":"Schuster V","articleTitle":"Hypoplasminogenemia","bookWebsiteJournalTitle":"Orphanet","date":"May 2008","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1393,"questionText":"What causes type 1 plasminogen deficiency?","answerText":"Type 1 plasminogen deficiency is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"https://ghr.nlm.nih.gov/gene/PLG\" target=\"_blank\">PLG</a></em> gene. This gene provides instructions for making a protein called&nbsp;<a href=\"http://omim.org/entry/173350\" target=\"_blank\">plasminogen</a>.[11690][11691]&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">Enzymes</a>&nbsp;called plasminogen activators convert plasminogen into the protein plasmin, whose function is to dissolve fibrin clots. Fibrin clots form scabs at a wound site, providing the framework for new tissue growth.[11690]&nbsp;<em>PLG</em> mutations can decrease the amount of plasminogen that is produced, alter its function, or both. When the mutations affect plasminogen levels as well as the activity of the protein, type 1 plasminogen deficiency results.[11690][11691] A reduction in functional plasminogen results in less plasmin, which allows fibrin to buildup. The excess fibrin and the resulting inflammation of the tissue result in the inflamed woody growth characteristic of this condition.[11690]&nbsp;<br />\r\n<br />","dateModified":"2016-06-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":11690,"authors":"","articleTitle":"Congenital plaminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11691,"authors":"Schuster V","articleTitle":"Hypoplasminogenemia","bookWebsiteJournalTitle":"Orphanet","date":"May 2008","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1397,"questionText":"Is type 1 plasminogen deficiency inherited? If so, in what manner?","answerText":"Type 1 plasminogen deficiency is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner. This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell.[11690] Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs and symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:<br />\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected,</li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier, like each parent, and&nbsp;</li>\r\n    <li>25% (1 in 4) chance to be unaffected and not be a carrier.</li>\r\n</ul>","dateModified":"2016-06-14T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":11690,"authors":"","articleTitle":"Congenital plaminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1396,"questionText":"How&nbsp;might&nbsp;type 1 plasminogen deficiency be treated?","answerText":"There is currently no established approach to treatment of type 1 plasminogen deficiency.[13159] However, some cases of ligneous conjunctivitis, the most common disease manifestation, have been successfully treated using a combination of surgery and plasminogen administration. Surgery alone to remove the eye growths can be a temporary fix; however, irritation secondary to surgery can result in recurrence. Other therapies that have been used in reports with varying degrees of success include corticosteroids, immunosuppressants (Cyclosporine), blood thinners (heparin), alpha-chymotrypsin (digestive enzyme), plasma infusion (white blood cells), and anti-virals.[825][11704] Clinical trials regarding the use of plasminogen replacement therapy are ongoing.[13158]","dateModified":"2017-03-07T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":825,"authors":"Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ","articleTitle":"","bookWebsiteJournalTitle":"Hemostasis and Thrombosis","date":"2005","placeOfPublication":"Philadelphia","publisher":"Lippincott Williams & Wilkins"},{"referenceId":11704,"authors":"Michael J. Ang, Konstantinos I. Papageorgiou, Shu-Hong Chang, Jocelyn Kohn, Helen Chokron Garneau, Robert A. Goldberg","articleTitle":"Topical Plasminogen as Adjunctive Treatment in Recurrent Ligneous Conjunctivitis","bookWebsiteJournalTitle":"Ophthal Plast Reconstr Surg","date":"April 8, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/27065432","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13158,"authors":"Fay WP","articleTitle":"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis","bookWebsiteJournalTitle":"UpToDate","date":"August, 2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":13159,"authors":"Celkan T","articleTitle":"Plasminogen deficiency","bookWebsiteJournalTitle":"J Thromb Thrombolysis","date":"January, 2017","volume":"43(1)","pages":"132-138","url":"","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":22823,"abbreviatedInquiry":"My son has type 1 plasminogen deficiency and currently has been diagnosed with ligneous conjunctivitis. Please provide any and all information that you have with respect to this disease.","caseQuestions":[{"questionId":1368,"questionText":"What is type 1 plasminogen deficiency?","answerText":"<strong>Type 1 plasminogen deficiency</strong> is a genetic condition&nbsp;associated with inflammed growths on the mucous membranes, the moist tissues that line body openings such as the eye, mouth, nasopharynx, trachea, and female genital tract.  The growths may be triggered by local injury and/or infection and often recur after removal. The growths are caused by the deposition of&nbsp;fibrin (a protein involved in blood clotting) and by&nbsp;inflammation. The most common clinical finding is ligneous ('wood-like') conjunctivitis, a condition marked by redness and subsequent formation of pseudomembranes of part of the eye that progresses to white, yellow-white or red thick masses with a wood-like consistency that replace the normal mucosa. This can lead to vision loss. Growths in other areas can also lead to medical problems; those that occur in the gastrointestinal tract can cause ulcers, and growth in the windpipe can lead to breathing problems. <a href=\"https://www.nlm.nih.gov/medlineplus/hydrocephalus.html\" target=\"_blank\">Hydrocephalus</a>&nbsp;may be&nbsp;present at birth in&nbsp;a small number of individuals.[824][11690] Type 1 plasminogen deficiency is caused by mutations in the <em><a href=\"https://ghr.nlm.nih.gov/gene/PLG\" target=\"_blank\">PLG</a></em> gene. It is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;pattern.[11690] Management depends upon the sites involved, but mainly focuses on managing the ligneous conjunctivitis.[11691]","dateModified":"2016-06-13T00:00:00","references":[{"referenceId":824,"authors":"Ginsburg D","articleTitle":"Hemophilia and Other Disorders of Hemostasis","bookWebsiteJournalTitle":"Emery and Rimoin's Principles and Practice of Medical Genetics, 5th ed","date":"2007","authors2":"Rimoin DL, Connor JM, Pyeritz RE, Korf BR","placeOfPublication":"Philadelphia","publisher":"Elsevier Ltd"},{"referenceId":11690,"authors":"","articleTitle":"Congenital plaminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11691,"authors":"Schuster V","articleTitle":"Hypoplasminogenemia","bookWebsiteJournalTitle":"Orphanet","date":"May 2008","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1394,"questionText":"What are the signs and symptoms of type 1 plasminogen deficiency?","answerText":"Type 1 plasminogen deficiency is characterized by the formation of inflamed growths on the mucous membranes. The area of the body most commonly affected is the conjunctiva, which are the mucous membranes that protect the white part of the eye (the sclera) and line the eyelids. The most common symptom&nbsp;of this disorder is ligneous conjunctivitis. This occurs when a buildup of a protein called fibrin causes inflammation of the conjunctiva (conjunctivitis), leading to thick, woody (ligneous), inflamed growths. The growths usually appear yellow, white, or red in color. Ligneous conjunctivitis most often occurs on the inside of the eyelids. These growths can lead to tearing of the cornea, scarring, and vision loss.&nbsp;<br />\r\n<br />\r\nOther, less commonly affected areas include the inside of the mouth and gums, ears, upper and lower gastrointestinal tract, lungs, and female reproductive tract. The central nervous system (brain and spinal cord) and skin may also be affected.[823][5987][11691]","dateModified":"2016-06-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":823,"authors":"Tefs K, Gueorguieva M, Klammt J, Allen CM, Aktas D, Anlar FY et al","articleTitle":"Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients","bookWebsiteJournalTitle":"Blood","date":"November 2006","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/16849641","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5987,"authors":"","articleTitle":"Congenital plasminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","url":"http://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","dateAccessed":"2013-04-29T00:00:00"},{"referenceId":11691,"authors":"Schuster V","articleTitle":"Hypoplasminogenemia","bookWebsiteJournalTitle":"Orphanet","date":"May 2008","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1396,"questionText":"How&nbsp;might&nbsp;type 1 plasminogen deficiency be treated?","answerText":"There is currently no established approach to treatment of type 1 plasminogen deficiency.[13159] However, some cases of ligneous conjunctivitis, the most common disease manifestation, have been successfully treated using a combination of surgery and plasminogen administration. Surgery alone to remove the eye growths can be a temporary fix; however, irritation secondary to surgery can result in recurrence. Other therapies that have been used in reports with varying degrees of success include corticosteroids, immunosuppressants (Cyclosporine), blood thinners (heparin), alpha-chymotrypsin (digestive enzyme), plasma infusion (white blood cells), and anti-virals.[825][11704] Clinical trials regarding the use of plasminogen replacement therapy are ongoing.[13158]","dateModified":"2017-03-07T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":825,"authors":"Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ","articleTitle":"","bookWebsiteJournalTitle":"Hemostasis and Thrombosis","date":"2005","placeOfPublication":"Philadelphia","publisher":"Lippincott Williams & Wilkins"},{"referenceId":11704,"authors":"Michael J. Ang, Konstantinos I. Papageorgiou, Shu-Hong Chang, Jocelyn Kohn, Helen Chokron Garneau, Robert A. Goldberg","articleTitle":"Topical Plasminogen as Adjunctive Treatment in Recurrent Ligneous Conjunctivitis","bookWebsiteJournalTitle":"Ophthal Plast Reconstr Surg","date":"April 8, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/27065432","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13158,"authors":"Fay WP","articleTitle":"Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis","bookWebsiteJournalTitle":"UpToDate","date":"August, 2015","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"},{"referenceId":13159,"authors":"Celkan T","articleTitle":"Plasminogen deficiency","bookWebsiteJournalTitle":"J Thromb Thrombolysis","date":"January, 2017","volume":"43(1)","pages":"132-138","url":"","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1393,"questionText":"What causes type 1 plasminogen deficiency?","answerText":"Type 1 plasminogen deficiency is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em><a href=\"https://ghr.nlm.nih.gov/gene/PLG\" target=\"_blank\">PLG</a></em> gene. This gene provides instructions for making a protein called&nbsp;<a href=\"http://omim.org/entry/173350\" target=\"_blank\">plasminogen</a>.[11690][11691]&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002353.htm\" target=\"_blank\">Enzymes</a>&nbsp;called plasminogen activators convert plasminogen into the protein plasmin, whose function is to dissolve fibrin clots. Fibrin clots form scabs at a wound site, providing the framework for new tissue growth.[11690]&nbsp;<em>PLG</em> mutations can decrease the amount of plasminogen that is produced, alter its function, or both. When the mutations affect plasminogen levels as well as the activity of the protein, type 1 plasminogen deficiency results.[11690][11691] A reduction in functional plasminogen results in less plasmin, which allows fibrin to buildup. The excess fibrin and the resulting inflammation of the tissue result in the inflamed woody growth characteristic of this condition.[11690]&nbsp;<br />\r\n<br />","dateModified":"2016-06-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":11690,"authors":"","articleTitle":"Congenital plaminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11691,"authors":"Schuster V","articleTitle":"Hypoplasminogenemia","bookWebsiteJournalTitle":"Orphanet","date":"May 2008","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=722","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1397,"questionText":"Is type 1 plasminogen deficiency inherited? If so, in what manner?","answerText":"Type 1 plasminogen deficiency is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner. This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell.[11690] Affected people inherit one mutated copy of the gene from each parent, who is referred to as a <a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs and symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:<br />\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected,</li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier, like each parent, and&nbsp;</li>\r\n    <li>25% (1 in 4) chance to be unaffected and not be a carrier.</li>\r\n</ul>","dateModified":"2016-06-14T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":11690,"authors":"","articleTitle":"Congenital plaminogen deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"August 2012","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/congenital-plasminogen-deficiency","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5613,"phenoTypeName":"Abnormality of vision","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7714,"phenoTypeName":"Decreased level of plasminogen","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14208,"phenoTypeName":"Gingival overgrowth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9812,"phenoTypeName":"Gingivitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14099,"phenoTypeName":"Abnormal fallopian tube morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11306,"phenoTypeName":"Abnormality of the middle ear","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9730,"phenoTypeName":"Abnormality of the ovary","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13719,"phenoTypeName":"Abnormality of the respiratory system","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10274,"phenoTypeName":"Abnormality of the skin","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12200,"phenoTypeName":"Cervicitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9394,"phenoTypeName":"Dandy-Walker malformation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13766,"phenoTypeName":"Duodenal ulcer","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9825,"phenoTypeName":"Hydrocephalus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10054,"phenoTypeName":"Nephritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14159,"phenoTypeName":"Nephrolithiasis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12628,"phenoTypeName":"Periodontitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","percentRanges":"-"},{"phenoTypeId":9181,"phenoTypeName":"Abnormality of the ear","percentRanges":"-"},{"phenoTypeId":4760,"phenoTypeName":"Abnormality of the larynx","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","percentRanges":"-"},{"phenoTypeId":9414,"phenoTypeName":"Cerebellar hypoplasia","percentRanges":"-"},{"phenoTypeId":5616,"phenoTypeName":"Conjunctivitis","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","percentRanges":"-"},{"phenoTypeId":7888,"phenoTypeName":"Recurrent upper respiratory tract infections","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Type_1_plasminogen_deficiency"}